Where Can You Report Your Adverse Drug Reactions Or Adverse Events Following Immunization

اين يمكنك التبليغ عن الاحداث الجانية للأدوية واللقاحات

Where Can You Report your Adverse Drug Reactions or Adverse Events Following Immunization

This section provides a comprehensive overview of the procedures and tools available to Healthcare Professionals, Market Authorization Holders and the General Public to report adverse events associated with medicinal products and vaccines in Lebanon.

How to report

You can send the case reports using the following tools:

For Healthcare Professionals and the Public

The Lebanese National Pharmacovigilance Program has adapted two user-friendly tools: one for Adverse Drug Reactions (Vigimobile e-Reporting e-Form) and another for reporting Adverse Events Following Immunization (Vigimobile e-Form). Both tools may be accessed by healthcare professionals and the general public.

The VigiMobile e-Form and e-Reporting e-Form:

The VigiMobile e-Form and e-Reporting e-Form are the latest tools launched in January 2025 by the Lebanese National Pharmacovigilance Program. These digital platforms were introduced to enhance the reporting process, with the e-Reporting e-Form designed for Adverse Drug Reactions (ADRs) and the VigiMobile e-Form specifically for Adverse Events Following Immunization (AEFIs).

How to Download on Android Phones

Scan the QR Code by pressing the link
Click the three dots in the top-right corner
Choose Install app
VigiMobile e-Form/e-Reporting e-Form now appears as an app

How to Download on Apple IOS Phones

Scan the QR Code by pressing the link
Click on the share button
Add VigiMobile to the home screen
VigiMobile e-Form/e-Reporting e-Form now appears as an app

How to Download on Windows

Press on the link
Install from the Browser menu
VigiMobile e-Form/e-Reporting e-Form is now installed

Scan QR Codes to Report:

ADRs Following Medication Use	AEFIs Following Vaccine Use

Or use the following link: LNPVP: e-Reporting eForm	Or use the following link: LNPVP: VigiMobile eForm

Direct Contact with the Lebanese National Pharmacovigilance Program:

You may contact the Lebanese National Pharmacovigilance Program through:

Email Address:

pv@moph.gov.lb, pv.moph@gmail.com

Phone number of the Quality Assurance of Pharmaceutical Products Program: 01-830254

For Market Authorization Holders:

Based on the Ministerial Resolution MR #181 issued in 2021, MAHs should adhere to the internationally agreed ICH guidelines and standards and send the reports in XML format as specified in ICH E2B (R2 or R3) guidelines

(https://www.moph.gov.lb/userfiles/files/Quality%26Safety/PharmacovigilanceSystemInLebanon/Karar%20181-2021.pdf).

All XML files should be sent to the following emails: pv@moph.gov.lb, and pv.moph@gmail.com.

As for what to report or report type, you can refer to Module VI:
https://moph.gov.lb/en/Pages/4/44742/pharmacovigilance-system-lebanon#/en/view/70479/lebanese-guideline-on-good-pharmacovigilance-practices-lgvp-

...

163

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01EE01	XALAPROST	G	Latanoprost - 0.005% w/v	0.005% w/v	Drops solution	421,967 L.L
S01EE01	MONOPROST	G	Latanoprost - 50mcg/ml	50mcg/ml	Drops solution	1,187,957 L.L
S01EE03	LUMIGAN	B	Bimatoprost - 0.1mg/ml	0.1mg/ml	Drops solution	740,457 L.L
S01EE04	TRAVONORM	G	Travoprost - 0.004%	0.004%	Drops	564,414 L.L
S01XA18	DRYFREE	G	Ciclosporin - 0.05%	0.05%	Drops	2,257,655 L.L
S02AA15	CETRAXAL OTICO	G	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops	821,088 L.L
S02AA30	OTOCOL	G	Chloramphenicol - 50mg/ml, Benzocaine - 50mg/ml		Drops	163,949 L.L
S02CA02	VIOCORTENE	B	Clioquinol - 10mg/ml, Flumetasone pivalate - 0.2mg/ml		Drops	568,253 L.L
S02DA01	OTIPAX	B	Lidocaine HCl - 1g/100g, Phenazone - 4g/100g		Drops	236,516 L.L
S03AA07	API-CIPROCIN	G	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops	530,818 L.L
R05DB13	SINECOD	B	Butamirate dihydrogenocitrate - 5mg/ml	5mg/ml	Drops	287,582 L.L
A11A	BEBE-VIT	G	Vitamin A - 1500IU/ml, Vitamin D3 - 400IU/ml, Vitamin E - 5mg/ml, Vitamin C - 40mg/ml, Vitamin B1 - 0.5mg/ml, Vitamin B2 - 0.6mg/ml, Vitamin B6 - 0.6mg/ml, Nicotinamide - 8mg/ml		Drops	287,582 L.L
B03AA07	PEDIAFER	G	Ferrous (sulfate) - 15mg/ml	15mg/ml	Drops	550,975 L.L
B03AB05	ENRICH N	G	Iron trivalent (hydroxide polymaltose complex) - 50mg/ml	50mg/ml	Drops	459,594 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.1%	0.1%	Drops	145,135 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Drops	241,892 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.1%	Drops	387,027 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
A11CC05	VIDROP	G	Vitamin D3 - 100IU/drop	100IU/drop	Drops	346,711 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 1%	1%	Drops	170,668 L.L
A03AX13	OVOL	B	Simethicone - 40mg/ml	40mg/ml	Drops	233,829 L.L
A03CB01	RESTROPINAL PEDIATRIC	B	Butobarbital - 2mg/ml, Methyl hyoscine nitrate - 0.1mg/ml		Drops	197,097 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01AA12	TOBRIN	G	Tobramycin - 0.3%	0.3%	Drops	169,324 L.L
S01AA13	FUCITHALMIC VISCOUS	B	Fusidic acid - 10mg/g	1%	Drops	443,468 L.L
S01AA13	OPTIFUCIN VISCOUS	G	Fusidic acid - 1%	1%	Drops	208,296 L.L
S01AE02	NAFLOX	G	Norfloxacin - 3mg/ml	3mg/ml	Drops	370,901 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
S01AE07	IMOX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	464,970 L.L
S01BC01	INDOCOLLYRE	B	Indometacine - 5mg/5ml	0.1%	Drops	408,528 L.L

...

163

...